JP2023502005A5 - - Google Patents
Info
- Publication number
- JP2023502005A5 JP2023502005A5 JP2022526450A JP2022526450A JP2023502005A5 JP 2023502005 A5 JP2023502005 A5 JP 2023502005A5 JP 2022526450 A JP2022526450 A JP 2022526450A JP 2022526450 A JP2022526450 A JP 2022526450A JP 2023502005 A5 JP2023502005 A5 JP 2023502005A5
- Authority
- JP
- Japan
- Prior art keywords
- linker
- sequence
- variant
- fatty acid
- bonded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023064366A JP7479539B2 (ja) | 2019-11-07 | 2023-04-11 | インターロイキン－２２の治療用誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19207766.7 | 2019-11-07 | ||
| EP19207766.7A EP3819307A1 (en) | 2019-11-07 | 2019-11-07 | Therapeutic derivatives of interleukin-22 |
| PCT/EP2020/081523 WO2021089875A1 (en) | 2019-11-07 | 2020-11-09 | Therapeutic derivatives of interleukin-22 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023064366A Division JP7479539B2 (ja) | 2019-11-07 | 2023-04-11 | インターロイキン－２２の治療用誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023502005A JP2023502005A (ja) | 2023-01-20 |
| JP2023502005A5 true JP2023502005A5 (enExample) | 2025-02-14 |
Family
ID=68502950
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526450A Pending JP2023502005A (ja) | 2019-11-07 | 2020-11-09 | インターロイキン－２２の治療用誘導体 |
| JP2023064366A Active JP7479539B2 (ja) | 2019-11-07 | 2023-04-11 | インターロイキン－２２の治療用誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023064366A Active JP7479539B2 (ja) | 2019-11-07 | 2023-04-11 | インターロイキン－２２の治療用誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US11806403B2 (enExample) |
| EP (2) | EP3819307A1 (enExample) |
| JP (2) | JP2023502005A (enExample) |
| KR (1) | KR20220097921A (enExample) |
| CN (2) | CN118359699A (enExample) |
| AU (1) | AU2020378648A1 (enExample) |
| BR (1) | BR112022008497A2 (enExample) |
| CA (1) | CA3160338A1 (enExample) |
| CL (1) | CL2022001185A1 (enExample) |
| CO (1) | CO2022005889A2 (enExample) |
| CR (1) | CR20220249A (enExample) |
| GE (2) | GEAP202415970A (enExample) |
| IL (1) | IL292657A (enExample) |
| MX (1) | MX2022005547A (enExample) |
| MY (1) | MY209488A (enExample) |
| PE (1) | PE20221279A1 (enExample) |
| PH (1) | PH12022551107A1 (enExample) |
| SA (1) | SA522432487B1 (enExample) |
| WO (1) | WO2021089875A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3819307A1 (en) | 2019-11-07 | 2021-05-12 | CytoKi Pharma ApS | Therapeutic derivatives of interleukin-22 |
| WO2021207662A1 (en) * | 2020-04-10 | 2021-10-14 | Genentech, Inc. | Use of il-22fc for the treatment or prevention of pneumonia, acute respiratory distress syndrome, or cytokine release syndrome |
| CN115955976A (zh) * | 2020-04-17 | 2023-04-11 | 小利兰·斯坦福大学董事会 | 工程化白介素-22多肽及其用途 |
| EP4389138A1 (en) | 2022-12-22 | 2024-06-26 | Cytoki Pharma ApS | Dosage regimen for interleukin-22 derivatives |
| JP2025542282A (ja) | 2022-12-22 | 2025-12-25 | サイトカイ・ファーマ・アーペーエス | インターロイキン－２２誘導体の投薬レジメン |
| CN119708194A (zh) * | 2023-09-28 | 2025-03-28 | 南京诺艾新生物技术有限公司 | Il-22突变体及其制备方法与应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR106F (enExample) | 1964-12-21 | |||
| CA2718634A1 (en) | 2008-03-21 | 2009-09-24 | Wyeth Llc | Antibodies against interleukin-10-like cytokines and uses therefor |
| TW201143790A (en) * | 2010-05-13 | 2011-12-16 | Univ Indiana Res & Tech Corp | Glucagon superfamily peptides exhibiting nuclear hormone receptor activity |
| JP2013533227A (ja) * | 2010-06-08 | 2013-08-22 | ノヴォ ノルディスク アー／エス | Ｆｇｆ２１類似体および誘導体 |
| ES2800983T3 (es) * | 2010-12-22 | 2021-01-07 | Baxalta GmbH | Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína |
| TW201315739A (zh) * | 2011-07-01 | 2013-04-16 | 拜耳智慧財產有限公司 | 鬆弛素（ｒｅｌａｘｉｎ）融合多肽類及其用途 |
| CA2878825A1 (en) | 2012-07-10 | 2014-01-16 | The Uab Research Foundation | Compositions and methods for modulation of il-20 family cytokine activity |
| PL2970422T3 (pl) | 2013-03-15 | 2018-09-28 | F.Hoffmann-La Roche Ag | Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania |
| WO2015038938A1 (en) * | 2013-09-13 | 2015-03-19 | The California Institute For Biomedical Research | Modified therapeutic agents and compositions thereof |
| US10695406B2 (en) | 2014-05-27 | 2020-06-30 | The University Of Queensland | Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent |
| MA41794A (fr) * | 2015-03-18 | 2018-01-23 | The California Institute For Biomedical Res | Agents thérapeutiques modifiés et compositions associées |
| CN106146668A (zh) | 2015-04-01 | 2016-11-23 | 中国人民解放军第二军医大学 | 长效白细胞介素22的制备方法及其用途 |
| HK1257747A1 (zh) * | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| IL321812A (en) * | 2017-08-03 | 2025-08-01 | Synthorx Inc | Cytokine complexes for the treatment of autoimmune diseases |
| CN111655717A (zh) | 2018-01-26 | 2020-09-11 | 豪夫迈·罗氏有限公司 | IL-22 Fc融合蛋白及使用方法 |
| EP3819307A1 (en) * | 2019-11-07 | 2021-05-12 | CytoKi Pharma ApS | Therapeutic derivatives of interleukin-22 |
| CN115955976A (zh) | 2020-04-17 | 2023-04-11 | 小利兰·斯坦福大学董事会 | 工程化白介素-22多肽及其用途 |
| US20240279297A1 (en) | 2021-05-11 | 2024-08-22 | Cytoki Pharma Aps | Therapeutic derivatives of interleukin-22 |
| EP4089107A1 (en) | 2021-05-11 | 2022-11-16 | CytoKi Pharma ApS | Therapeutic derivatives of interleukin-22 |
| EP4089108A1 (en) | 2021-05-11 | 2022-11-16 | CytoKi Pharma ApS | Therapeutic derivatives of interleukin-22 |
-
2019
- 2019-11-07 EP EP19207766.7A patent/EP3819307A1/en not_active Withdrawn
-
2020
- 2020-11-09 CR CR20220249A patent/CR20220249A/es unknown
- 2020-11-09 JP JP2022526450A patent/JP2023502005A/ja active Pending
- 2020-11-09 MY MYPI2022002375A patent/MY209488A/en unknown
- 2020-11-09 CA CA3160338A patent/CA3160338A1/en active Pending
- 2020-11-09 EP EP20800949.8A patent/EP4055035A1/en active Pending
- 2020-11-09 GE GEAP202415970A patent/GEAP202415970A/en unknown
- 2020-11-09 GE GEAP202015970A patent/GEP20257757B/en unknown
- 2020-11-09 KR KR1020227017744A patent/KR20220097921A/ko not_active Ceased
- 2020-11-09 MX MX2022005547A patent/MX2022005547A/es unknown
- 2020-11-09 BR BR112022008497A patent/BR112022008497A2/pt unknown
- 2020-11-09 CN CN202410470634.7A patent/CN118359699A/zh active Pending
- 2020-11-09 CN CN202080077355.4A patent/CN114761422B/zh active Active
- 2020-11-09 PH PH1/2022/551107A patent/PH12022551107A1/en unknown
- 2020-11-09 WO PCT/EP2020/081523 patent/WO2021089875A1/en not_active Ceased
- 2020-11-09 AU AU2020378648A patent/AU2020378648A1/en not_active Abandoned
- 2020-11-09 PE PE2022000734A patent/PE20221279A1/es unknown
-
2022
- 2022-05-01 IL IL292657A patent/IL292657A/en unknown
- 2022-05-03 SA SA522432487A patent/SA522432487B1/ar unknown
- 2022-05-04 CL CL2022001185A patent/CL2022001185A1/es unknown
- 2022-05-05 CO CONC2022/0005889A patent/CO2022005889A2/es unknown
- 2022-05-05 US US17/737,849 patent/US11806403B2/en active Active
-
2023
- 2023-04-11 JP JP2023064366A patent/JP7479539B2/ja active Active
- 2023-06-30 US US18/345,775 patent/US20230381320A1/en not_active Abandoned
- 2023-06-30 US US18/345,832 patent/US12447211B2/en active Active
-
2024
- 2024-04-05 US US18/628,440 patent/US12226487B2/en active Active
-
2025
- 2025-09-25 US US19/340,190 patent/US20260014257A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4370146A2 (en) | Lipidated peptide inhibitors of interleukin-23 receptor | |
| JP6682432B2 (ja) | Ｇｉｐ−ｇｌｐ−１デュアルアゴニスト化合物及び方法 | |
| JP2013517307A5 (enExample) | ||
| AU2012357739A1 (en) | Glucagon analogues | |
| JP2020045362A (ja) | グルカゴン−ｇｌｐ−１−ｇｉｐトリプルアゴニスト化合物 | |
| JP2016501204A5 (enExample) | ||
| SG186764A1 (en) | Glucagon analogues | |
| WO2016066818A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| JP2012532898A (ja) | アシル化グルカゴン類似体 | |
| JP2022509568A5 (enExample) | ||
| CN105745222A (zh) | 酰化胰高血糖素类似物 | |
| JP2020535138A5 (enExample) | ||
| JP2008539713A5 (enExample) | ||
| JP2008507298A5 (enExample) | ||
| WO2022253202A1 (zh) | 一种glp-1r和gipr双重靶向激动作用的多肽衍生物及其制备方法和用途 | |
| JP6158097B2 (ja) | 炎症を抑制するためのペプチド | |
| WO2024193606A1 (zh) | 肠促胰岛素类似物及其应用 | |
| CN118359699A (zh) | 白细胞介素-22的治疗性衍生物 | |
| JP2024516613A5 (enExample) | ||
| JP2022500453A (ja) | 線維症、ｎａｓｈ、及び、ｎａｆｌｄを治療する方法での使用のためのトリプトリド、及び、そのプロドラッグ | |
| JP2024502740A5 (enExample) | ||
| TWI861797B (zh) | 多肽在製備治療和/或預防糖尿病及肥胖症及其相關疾病藥物中的製藥用途 | |
| CN118085062A (zh) | 一种作为gcgr和glp-1r双受体激动剂的多肽衍生物及其制备方法和用途 | |
| JP2023538236A5 (enExample) | ||
| WO2007009359A1 (en) | Thymosin beta 4 derivatives and use thereof |